48
Management of A.F. patients with the DawnAC induction module David Hirst MidYorkshire Hospitals NHS Trust

Management of A.F. patients with the DawnAC induction module

  • Upload
    tex

  • View
    87

  • Download
    0

Embed Size (px)

DESCRIPTION

Management of A.F. patients with the DawnAC induction module. David Hirst MidYorkshire Hospitals NHS Trust. Fennerty v5 software. Glasgow from table. Integrated Glasgow v6 software. Referrals to clinic. Out patient referrals In patients referred direct from wards. Out-patient referrals. - PowerPoint PPT Presentation

Citation preview

Page 1: Management of A.F. patients with the DawnAC induction module

Management of A.F. patients with the DawnAC induction module

David HirstMidYorkshire Hospitals NHS

Trust

Page 2: Management of A.F. patients with the DawnAC induction module

Referrals to anticoagulant clinic per month

0

5

10

15

20

25

30

35

40

45

50

year

nu

mb

er

total

AF

all others

1996 1997 1998 1999 2000 2001 2002

12

23

17

23

3540

21729

11646

10083

INRs

Fennerty v5 software

Glasgow from table

Integrated Glasgow v6 software

Page 3: Management of A.F. patients with the DawnAC induction module

Referrals to clinic Out patient referrals In patients referred direct from

wards

Page 4: Management of A.F. patients with the DawnAC induction module

Out-patient referrals Up to 4 a week Written referral request mandatory Details transferred onto warfarin dosing

chart and new patient manager etc. completed

Warfarin prescription done by consultant haematologist

Page 5: Management of A.F. patients with the DawnAC induction module

Out-patient referrals Wed am…details confirmed/updated,

counselled Start warfarin (5mg) on Friday and

attend for INR on days 5 and 8 (following Tuesday and Friday)

Dosed by induction algorithm, results telephoned, yellow book returned

Aspirin stops when INR therapeutic (if have written confirmation)

Day8, transferred to maintenance

Page 6: Management of A.F. patients with the DawnAC induction module

Ward referrals Dosing chart acts as referral request New patient manager, treatment plan

completed INR, warfarin dose and date of next INR

written on dosing chart and sent back to ward

Patient counselled before discharge Patient may be discharged during

induction

Page 7: Management of A.F. patients with the DawnAC induction module

Ward referrals Day8, transferred to maintenance In-patient, continue with dosing chart

with INR checks on a regular basis If discharged, further INRs at hospital or

in community by dose/post using yellow book

Page 8: Management of A.F. patients with the DawnAC induction module
Page 9: Management of A.F. patients with the DawnAC induction module
Page 10: Management of A.F. patients with the DawnAC induction module
Page 11: Management of A.F. patients with the DawnAC induction module
Page 12: Management of A.F. patients with the DawnAC induction module
Page 13: Management of A.F. patients with the DawnAC induction module
Page 14: Management of A.F. patients with the DawnAC induction module
Page 15: Management of A.F. patients with the DawnAC induction module
Page 16: Management of A.F. patients with the DawnAC induction module
Page 17: Management of A.F. patients with the DawnAC induction module
Page 18: Management of A.F. patients with the DawnAC induction module
Page 19: Management of A.F. patients with the DawnAC induction module
Page 20: Management of A.F. patients with the DawnAC induction module
Page 21: Management of A.F. patients with the DawnAC induction module
Page 22: Management of A.F. patients with the DawnAC induction module

Only 32/175 UK sites (18%) have integrated induction module…why?

Expensive luxury…£1838 special offer

Read algorithm from a table and enter results as treatment history

Induction not done…work volume, staffing levels

Page 23: Management of A.F. patients with the DawnAC induction module

Why use integrated induction package ?

User friendly Seamless transition to

maintenance Safety features (best practice) Government guidelines Litigation I’m on 10% commission…I wish

Page 24: Management of A.F. patients with the DawnAC induction module

Safety features Human error…misread table Import results…reduce

transcription error Calculation prevention Warnings

Page 25: Management of A.F. patients with the DawnAC induction module

Calculation prevention No matching rule for day INR greater than cut-off (5.0) No matching rule for previous dose Dialogue box to enter dose, any miss

days and interval…algorithm shown to aid decision

No matching rule for INR No dialogue box…problem with algorithm

Page 26: Management of A.F. patients with the DawnAC induction module
Page 27: Management of A.F. patients with the DawnAC induction module

Warnings generated on calculation

Large INR change (>=INR entered in setup)

INR less than previous INR and low Review for transfer

Page 28: Management of A.F. patients with the DawnAC induction module

Warnings with confirmation prompt Given on accepting dose and next test

date for both manual and computer calculated values

Dose increased for INR rising to within range or high

Dose decreased for INR falling to within range or low

Miss days greater than 2 Next test interval greater than protocol

maximum

Page 29: Management of A.F. patients with the DawnAC induction module

PRODIGY guidelines for warfarin therapy in AFwww.prodigy.nhs.uk

An INR of 2.0 can usually be reached by giving warfarin 5 mg for 4-5 days.

People on warfarin need regular monitoring of INR. Ideally this should take place in the setting of an organized anticoagulant clinic.

If no clinic is available, monitor INR daily until the result has stayed in the therapeutic range for at least 2 consecutive days. Then check INR 2-3 times a week for 1-2 weeks, and then less often, depending on the stability of the results.

Page 30: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg

4mg

3mg

2mg

1mg

1.7

1.8

2.22.3

2.7

2.8

3.23.3

3.7

3.8

1.71.8

2.4

2.5

3.0

3.1

3.53.6

1 15 8

OMIT

Page 31: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg

4mg

3mg

2mg

1mg

6.0mg x 7days

5.0mg x 7days

1.7

1.8

2.22.3

2.7

2.8

3.23.3

3.7

3.8

1.71.8

2.4

2.5

3.0

3.1

3.5

4.0mg x 7days

3.0mg x 4days

3.6

1 15 8

OMIT

Page 32: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg

4mg

3mg

2mg

1mg

5.0mg x 7days6.0mg x 7days

4.0mg x 7days5.0mg x 7days

1.7

1.8

2.22.3

2.7

2.8

3.23.3

3.7

3.8

1.71.8

2.4

2.5

3.0

3.1

3.5

3.5mg x 7days4.0mg x 7days

3.0mg x 4days

2.5mg x 4days3.6

1 15 8

OMIT

Page 33: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg

4mg

3mg

2mg

1mg

4.0mg x 7days5.0mg x 7days6.0mg x 7days

3.5mg x 7days4.0mg x 7days5.0mg x 7days

1.7

1.8

2.22.3

2.7

2.8

3.23.3

3.7

3.8

1.71.8

2.4

2.5

3.0

3.1

3.5

3.0mg x 7days3.5mg x 7days4.0mg x 7days

2.5mg x 4days3.0mg x 4days

2.0mg x 4days2.5mg x 4days3.6

1 15 8

OMIT

Page 34: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg

4mg

3mg

2mg

1mg

3.0mg x 7days4.0mg x 7days5.0mg x 7days6.0mg x 7days

2.5mg x 7days3.5mg x 7days4.0mg x 7days5.0mg x 7days

1.7

1.8

2.22.3

2.7

2.8

3.23.3

3.7

3.8

1.71.8

2.4

2.5

3.0

3.1

3.5

2.0mg x 7days3.0mg x 7days3.5mg x 7days4.0mg x 7days

1.5mg x 4days2.5mg x 4days3.0mg x 4days

1.0mg x 4days2.0mg x 4days2.5mg x 4days3.6

1 15 8

OMIT

Page 35: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg

4mg

3mg

2mg

1mg

2.0mg x 7days3.0mg x 7days4.0mg x 7days5.0mg x 7days6.0mg x 7days

1.5mg x 7days2.5mg x 7days3.5mg x 7days4.0mg x 7days5.0mg x 7days

1.7

1.8

2.22.3

2.7

2.8

3.23.3

3.7

3.8

1.71.8

2.4

2.5

3.0

3.1

3.5

1.0mg x 7days2.0mg x 7days3.0mg x 7days3.5mg x 7days4.0mg x 7days

0.5mg x 4days1.5mg x 4days2.5mg x 4days3.0mg x 4days

OMIT x 4days1.0mg x 4days2.0mg x 4days2.5mg x 4days3.6

1 15 8

OMIT

Page 36: Management of A.F. patients with the DawnAC induction module

The Tait Algorithm

1

1.5

2

2.5

3

3.5

4

1 2 3

Induction day

INR

5mg

5mg4mg

3mg

2mg

1mg

1.7

1.8

2.2

2.3

2.7

2.8

3.23.3

3.7

3.8

1.9

2.0

2.9

3.0

3.5

1 15 8

OMIT 0.5mg x 4days

1.0mg x 4days

1.5mg x 4days

Page 37: Management of A.F. patients with the DawnAC induction module

Analysis of induction algorithm Foxfire…258 induction records

dosed on days 1,5,8 Time taken to 2 consecutive INRs

2.0-4.0 post induction Was day8 dose accurate or did it

overdose/underdose

Page 38: Management of A.F. patients with the DawnAC induction module

Analysis of the Tait Algorithm

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

8.00

9.00

10.00

11.00

12.00

13.00

14.00

15.00

16.00

17.00

18.00

0.0 7.0 14.0 21.0 28.0 35.0 42.0 49.0 56.0 63.0 70.0 77.0 84.0 91.0 98.0 105.0 112.0 119.0 126.0 133.0 140.0 147.0

Days to acheive INR>2.0<4.0

Day

8 w

arfa

rin

mg

Day 8 Dose mg N % 5 8 15 >15 LOW HIGH OK

6.0 40 16 0 0 35 655.0 54 21 0 63 87 134.0 39 15 26 72 97 33.5 24 9 25 71 96 43.0 32 12.5 50 44 97 32.5 18 7 72 11 89 112.0 11 4 36 0 36 641.5 19 7.5 0 0 16 841.0 10 4 0 0 0 1000.5 8 3 0 0 0 1000.0 3 1 0 0 33 67

Total 258 100% of total 19 55 69 31

% induced by day % Day 8 Dose

Page 39: Management of A.F. patients with the DawnAC induction module

Analysis of the Tait Algorithm

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

8.00

9.00

10.00

11.00

12.00

13.00

14.00

15.00

16.00

17.00

18.00

0.0 7.0 14.0 21.0 28.0 35.0 42.0 49.0 56.0 63.0 70.0 77.0 84.0 91.0 98.0 105.0 112.0 119.0 126.0 133.0 140.0 147.0

Days to acheive INR>2.0<4.0

Act

ual

War

fari

n n

eed

ed m

g

Day 8 Dose mg N % 5 8 15 >15 LOW HIGH OK

6.0 40 16 0 0 35 65 55 10 355.0 54 21 0 63 87 13 13 4 834.0 39 15 26 72 97 3 0 3 973.5 24 9 25 71 96 4 0 4 963.0 32 12.5 50 44 97 3 0 3 972.5 18 7 72 11 89 11 6 11 832.0 11 4 36 0 36 64 64 0 361.5 19 7.5 0 0 16 84 95 0 51.0 10 4 0 0 0 100 100 0 00.5 8 3 0 0 0 100 100 0 00.0 3 1 0 0 33 67 100 0 0

Total 258 100% of total 19 55 69 31 30 4 66

% induced by day % Day 8 DoseDay 8 Dose mg N % 5 8 15 >15 LOW HIGH OK

6.0 40 16 0 0 35 65 0 10 905.0 54 21 0 63 87 13 0 4 964.0 39 15 26 72 97 3 0 3 973.5 24 9 25 71 96 4 0 4 963.0 32 12.5 50 44 97 3 0 3 972.5 18 7 72 11 89 11 6 11 832.0 11 4 36 0 36 64 64 0 361.5 19 7.5 0 0 16 84 95 0 51.0 10 4 0 0 0 100 100 0 00.5 8 3 0 0 0 100 100 0 00.0 3 1 0 0 33 67 100 0 0

Total 258 100% of total 19 55 69 31 18 4 78

% induced by day % Day 8 Dose

Page 40: Management of A.F. patients with the DawnAC induction module

Analysis summary

Acceptable, covered by Aspirin

Unacceptable, Aspirin stopped. Most sensitive to warfarin taking longer to induct. ?increase by 1mg

No problem

No problem

day8 dose 15days >15days low high OK

6.0mg, 5.0mg 65% 35% 31% 6% 63%

4.0,3.5,3.0,2.5mg 97% 3% 3% 97%

2mg day8 INR>day5 100% 100%

2mg day8 INR<day5 100% 100%

1.5,1.0,0.5,0.0mg 10% 90% 98% 2%% of Total 69% 31% 18% 4% 78%

day 8 doseinduced by

Page 41: Management of A.F. patients with the DawnAC induction module
Page 42: Management of A.F. patients with the DawnAC induction module
Page 43: Management of A.F. patients with the DawnAC induction module
Page 44: Management of A.F. patients with the DawnAC induction module
Page 45: Management of A.F. patients with the DawnAC induction module
Page 46: Management of A.F. patients with the DawnAC induction module
Page 47: Management of A.F. patients with the DawnAC induction module
Page 48: Management of A.F. patients with the DawnAC induction module

What can be done? Tweak algorithm Warning when day8 INR < day5 Advise to restart aspirin Have higher post induction target

INR Let INR fall to baseline and restart on

a different algorithm ‘Intelligent’ algorithm